{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:55:21Z","timestamp":1789617321024,"version":"build-2803163510"},"reference-count":224,"publisher":"Elsevier","isbn-type":[{"value":"9780128211663","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/bs.acc.2019.11.004","type":"book-chapter","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T08:50:55Z","timestamp":1576140655000},"page":"85-135","source":"Crossref","is-referenced-by-count":27,"title":["Neurotransmitter, neuropeptide and gut peptide profile in PCOS-pathways contributing to the pathophysiology, food intake and psychiatric manifestations of PCOS"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.acc.2019.11.004_bb0010","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/bs.acc.2019.11.004_bb0015","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/1933719117728803","article-title":"Neuroendocrine regulation of food intake in polycystic ovary syndrome","volume":"25","author":"Romualdi","year":"2018","journal-title":"Reprod. Sci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.acc.2019.11.004_bb0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr. Rev."},{"key":"10.1016\/bs.acc.2019.11.004_bb0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"Polycystic ovary syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2019.11.004_bb0035","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.fertnstert.2007.11.022","article-title":"Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study","volume":"91","author":"Kerchner","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.acc.2019.11.004_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/AOG.0b013e318202b0a4","article-title":"Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"117","author":"Dokras","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.fertnstert.2011.10.022","article-title":"Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"97","author":"Dokras","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.acc.2019.11.004_bb0060","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2018.01.038","article-title":"Androgen excess-polycystic ovary syndrome society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome","volume":"109","author":"Dokras","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.acc.2019.11.004_bb0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/bs.acc.2018.05.003","article-title":"Advances in PCOS pathogenesis and progression-mitochondrial mutations and dysfunction","volume":"86","author":"Ilie","year":"2018","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/bs.acc.2019.11.004_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2009.05.012","article-title":"The role of the endogenous opioid system in polycystic ovary syndrome","volume":"92","author":"Eyvazzadeh","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.acc.2019.11.004_bb0075","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00404-011-1947-1","article-title":"Co-involvement of psychological and neurological abnormalities in infertility with polycystic ovarian syndrome","volume":"284","author":"Shi","year":"2011","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/bs.acc.2019.11.004_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001547","article-title":"Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010","volume":"10","author":"Ferrari","year":"2013","journal-title":"PLoS Med."},{"issue":"Suppl 1","key":"10.1016\/bs.acc.2019.11.004_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1468-1331.2005.01196.x","article-title":"Cost of anxiety disorders in Europe","volume":"12","author":"Andlin-Sobocki","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0090","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/nn.4112","article-title":"Sex differences and stress across the lifespan","volume":"18","author":"Bale","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yfrne.2017.05.002","article-title":"Polycystic ovary syndrome: understanding the role of the brain","volume":"46","author":"Moore","year":"2017","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0100","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.steroids.2011.12.008","article-title":"Mood and anxiety disorders in women with PCOS","volume":"77","author":"Dokras","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/bs.acc.2019.11.004_bb0105","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/jog.12696","article-title":"Psychiatric comorbidity in women with polycystic ovary syndrome","volume":"41","author":"Annagur","year":"2015","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/bs.acc.2019.11.004_bb0110","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1093\/humrep\/des114","article-title":"Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome","volume":"27","author":"Moran","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/bs.acc.2019.11.004_bb0115","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/humrep\/dep384","article-title":"Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index","volume":"25","author":"Jedel","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/bs.acc.2019.11.004_bb0120","first-page":"811","article-title":"The relationship between clinicobiochemical markers and depression in women with polycystic ovary syndrome","volume":"12","author":"Rahiminejad","year":"2014","journal-title":"Int. J. Reprod. Med."},{"issue":"2","key":"10.1016\/bs.acc.2019.11.004_bb0125","doi-asserted-by":"crossref","DOI":"10.5812\/ijpbs.6595","article-title":"Psychosomatic aspects of polycystic ovarian syndrome: a review","volume":"11","author":"Azizi","year":"2017","journal-title":"Iran J. Psychiatry Behav. Sci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1359105306065021","article-title":"Depression and body image among women with polycystic ovary syndrome","volume":"11","author":"Himelein","year":"2006","journal-title":"J. Health Psychol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0135","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jc.2009-0837","article-title":"Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome","volume":"94","author":"Vassiliadi","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0140","doi-asserted-by":"crossref","first-page":"14348","DOI":"10.1073\/pnas.1507514112","article-title":"Maternal testosterone exposure increases anxiety-like behavior and impacts the limbic system in the offspring","volume":"112","author":"Hu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.acc.2019.11.004_bb0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.mp.4001949","article-title":"Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies","volume":"12","author":"Ruhe","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/bs.acc.2019.11.004_bb0150","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.yfrne.2009.05.006","article-title":"Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides","volume":"30","author":"Do Rego","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0155","first-page":"71","article-title":"Neurotransmitter alteration in a testosterone propionate-induced polycystic ovarian syndrome rat model","volume":"29","author":"Chaudhari","year":"2017","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"key":"10.1016\/bs.acc.2019.11.004_bb0160","first-page":"488","article-title":"Psychiatric disorders related to polycystic ovary syndrome","volume":"63","author":"Krepula","year":"2012","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.15171\/jcs.2015.023","article-title":"Psychosocial factors associated with polycystic ovary syndrome: a case control study","volume":"4","author":"Sayyah-Melli","year":"2015","journal-title":"J. Caring Sci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0170","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.fertnstert.2006.11.039","article-title":"Increased risk of depressive disorders in women with polycystic ovary syndrome","volume":"87","author":"Hollinrake","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.acc.2019.11.004_bb0175","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/humrep\/16.4.765","article-title":"Polycystic ovaries and eating disorders: are they related?","volume":"16","author":"Michelmore","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/bs.acc.2019.11.004_bb0180","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2265.1992.tb02262.x","article-title":"Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance","volume":"36","author":"Robinson","year":"1992","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/bs.acc.2019.11.004_bb0185","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.fertnstert.2005.12.054","article-title":"Difference in dietary intake between women with polycystic ovary syndrome and healthy controls","volume":"86","author":"Douglas","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.acc.2019.11.004_bb0190","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-61-5-946","article-title":"Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome","volume":"61","author":"Wild","year":"1985","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0195","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2003-031583","article-title":"Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition","volume":"89","author":"Moran","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09513590400002300","article-title":"Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome","volume":"19","author":"Hirschberg","year":"2004","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12958-018-0354-x","article-title":"GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile","volume":"16","author":"Chaudhari","year":"2018","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0210","first-page":"122:1","article-title":"Neural signals that regulate GnRH neurones directly during the oestrous cycle","author":"Smith","year":"2001","journal-title":"Reproduction"},{"key":"10.1016\/bs.acc.2019.11.004_bb0215","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.steroids.2011.12.007","article-title":"Neuroendocrine dysfunction in polycystic ovary syndrome","volume":"77","author":"Burt Solorzano","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/bs.acc.2019.11.004_bb0220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1210\/endo-99-1-243","article-title":"Pituitary stalk portal blood collection in rhesus monkeys: evidence for pulsatile release of gonadotropin-releasing hormone (GnRH)","volume":"99","author":"Carmel","year":"1976","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0225","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.ph.49.030187.002053","article-title":"Central actions of ovarian steroids in the feedback regulation of pulsatile secretion of luteinizing hormone","volume":"49","author":"Karsch","year":"1987","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0889-8529(05)70071-2","article-title":"Neuroendocrine aspects of polycystic ovary syndrome","volume":"28","author":"Marshall","year":"1999","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/bs.acc.2019.11.004_bb0235","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0240","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0015-0282(97)81873-0","article-title":"Prenatal exposure of female rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthood","volume":"67","author":"Dumesic","year":"1997","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.acc.2019.11.004_bb0245","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/hbeh.2000.1608","article-title":"Timing of prenatal androgen exposure: anatomical and endocrine effects on juvenile male and female rhesus monkeys","volume":"38","author":"Herman","year":"2000","journal-title":"Horm. Behav."},{"key":"10.1016\/bs.acc.2019.11.004_bb0250","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1095\/biolreprod.108.067702","article-title":"Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys","volume":"79","author":"Abbott","year":"2008","journal-title":"Biol. Reprod."},{"key":"10.1016\/bs.acc.2019.11.004_bb0255","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1073\/pnas.0308058101","article-title":"Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder","volume":"101","author":"Sullivan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.acc.2019.11.004_bb0260","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1073\/pnas.1415038112","article-title":"Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome","volume":"112","author":"Moore","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.acc.2019.11.004_bb0265","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1210\/jcem-63-1-215","article-title":"Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome?","volume":"63","author":"Dunaif A","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0270","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-2007-984741","article-title":"Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty","volume":"25","author":"Blank","year":"2007","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/bs.acc.2019.11.004_bb0275","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1210\/en.2005-1029","article-title":"Androgens increase gonadotropin-releasing hormone neuron firing activity in females and interfere with progesterone negative feedback","volume":"147","author":"Pielecka","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0280","first-page":"119","article-title":"Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome","volume":"79","author":"Apter","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0285","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1210\/jcem-71-4-970","article-title":"Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life","volume":"71","author":"Apter","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0290","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1210\/jc.2004-2359","article-title":"Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls","volume":"90","author":"Chhabra","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0295","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-8993(93)90094-4","article-title":"Absence of androgen receptors in LHRH immunoreactive neurons","volume":"624","author":"Huang","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/bs.acc.2019.11.004_bb0300","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/en.2012-1302","article-title":"Release of norepinephrine in the preoptic area activates anteroventral periventricular nucleus neurons and stimulates the surge of luteinizing hormone","volume":"154","author":"Szawka","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0305","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2826.2004.01235.x","article-title":"Interaction between norepinephrine, oxytocin, and nitric oxide in the stimulation of gonadotropin-releasing hormone release from proestrous rat basal hypothalamus explants","volume":"16","author":"Selvage","year":"2004","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0310","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/en.2007-1241","article-title":"Norepinephrine suppresses gonadotropin-releasing hormone neuron excitability in the adult mouse","volume":"149","author":"Han","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0315","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jne.12293","article-title":"Evidence for Changes in Numbers of Synaptic Inputs onto KNDy and GnRH Neurones during the Preovulatory LH Surge in the Ewe","volume":"27","author":"Merkley","year":"2015","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0320","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jsbmb.2015.10.002","article-title":"The neuroendocrine genesis of polycystic ovary syndrome: a role for arcuate nucleus GABA neurons","volume":"160","author":"Moore","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0325","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1528-1167.2010.02897.x","article-title":"Antiepileptic drugs, sex hormones, and PCOS","volume":"52","author":"Verrotti","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/bs.acc.2019.11.004_bb0330","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1528-1167.2007.01100.x","article-title":"Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study","volume":"48","author":"Prabhakar","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/bs.acc.2019.11.004_bb0335","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1528-1157.2001.0420081002.x","article-title":"Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy","volume":"42","author":"Stephen","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/bs.acc.2019.11.004_bb0340","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s10571-007-9201-x","article-title":"Valproic acid alters GnRH-GABA interactions in cycling female rats","volume":"27","author":"Lakhanpal","year":"2007","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0345","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0006-8993(00)02939-5","article-title":"Sodium valproate alters GnRH-GABA interactions during development in seizure-prone mice","volume":"885","author":"Illig","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/bs.acc.2019.11.004_bb0350","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2826.2011.02145.x","article-title":"Depolarising and hyperpolarising actions of GABA(A) receptor activation on gonadotrophin-releasing hormone neurones: towards an emerging consensus","volume":"23","author":"Herbison","year":"2011","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0355","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000127190","article-title":"Expression of estrogen and progesterone receptors in glutamate and GABA neurons of the pubertal female monkey hypothalamus","volume":"65","author":"Thind","year":"1997","journal-title":"Neuroendocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0360","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000125962","article-title":"Estrogen induces ultrastructural changes in progesterone receptor-containing GABA neurons of the primate hypothalamus","volume":"54","author":"Leranth","year":"1991","journal-title":"Neuroendocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0365","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1095\/biolreprod.104.033126","article-title":"GABAergic integration of progesterone and androgen feedback to gonadotropin-releasing hormone neurons","volume":"72","author":"Sullivan","year":"2005","journal-title":"Biol. Reprod."},{"key":"10.1016\/bs.acc.2019.11.004_bb0370","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fendo.2019.00329","article-title":"Modulation of gonadotropin-releasing hormone neuron activity and secretion in mice by non-peptide neurotransmitters, gasotransmitters, and gliotransmitters","volume":"10","author":"Spergel","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0375","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1210\/me.2002-0163","article-title":"Activation of A-type gamma-aminobutyric acid receptors excites gonadotropin-releasing hormone neurons","volume":"16","author":"DeFazio","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0380","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/humrep\/dex086","article-title":"Increased cerebrospinal fluid levels of GABA, testosterone and estradiol in women with polycystic ovary syndrome","volume":"32","author":"Kawwass","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/bs.acc.2019.11.004_bb0385","doi-asserted-by":"crossref","first-page":"E683","DOI":"10.1152\/ajpendo.00532.2009","article-title":"Lack of functional GABA(B) receptors alters GnRH physiology and sexual dimorphic expression of GnRH and GAD-67 in the brain","volume":"298","author":"Catalano","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0390","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1210\/en.2010-0314","article-title":"Knockdown of GABA(A) receptor signaling in GnRH neurons has minimal effects upon fertility","volume":"151","author":"Lee","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0395","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1210\/endo-126-5-2499","article-title":"Stimulation of luteinizing hormone release by gamma-aminobutyric acid (GABA) agonists: mediation by GABAA-type receptors and activation of chloride and voltage-sensitive calcium channels","volume":"126","author":"Virmani","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1080001","article-title":"Effects of gamma-aminobutyric acid receptor agonists on the secretion of growth hormone, luteinizing hormone, adrenocorticotrophic hormone and thyroid-stimulating hormone from the rat pituitary gland in vitro","volume":"108","author":"Anderson","year":"1986","journal-title":"J. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0405","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1210\/endo.142.6.8180","article-title":"Estradiol enhances excitatory gamma-aminobutyric [corrected] acid-mediated calcium signaling in neonatal hypothalamic neurons","volume":"142","author":"Perrot-Sinal","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0410","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/gcen.1998.7155","article-title":"Cellular mechanism of pulsatile LHRH release","volume":"112","author":"Terasawa","year":"1998","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0415","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.neuropharm.2011.05.008","article-title":"Chronic exposure to anabolic androgenic steroids alters activity and synaptic function in neuroendocrine control regions of the female mouse","volume":"61","author":"Penatti","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0420","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1523\/JNEUROSCI.5383-09.2010","article-title":"Altered GABAA receptor-mediated synaptic transmission disrupts the firing of gonadotropin-releasing hormone neurons in male mice under conditions that mimic steroid abuse","volume":"30","author":"Penatti","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0425","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1210\/en.2011-0117","article-title":"Developmental programming: reproductive endocrinopathies in the adult female sheep after prenatal testosterone treatment are reflected in altered ontogeny of GnRH afferents","volume":"152","author":"Jansen","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0430","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1523\/JNEUROSCI.2304-17.2018","article-title":"Prepubertal development of gabaergic transmission to gonadotropin-releasing hormone (GnRH) neurons and postsynaptic response are altered by prenatal androgenization","volume":"38","author":"Berg","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.99405","article-title":"Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS","volume":"3","author":"Silva","year":"2018","journal-title":"JCI Insight."},{"key":"10.1016\/bs.acc.2019.11.004_bb0440","first-page":"61","article-title":"GABA system in schizophrenia and mood disorders: a mini review on third-generation imaging studies","volume":"7","author":"Chiapponi","year":"2016","journal-title":"Front. Psych."},{"key":"10.1016\/bs.acc.2019.11.004_bb0445","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.psyneuen.2016.05.010","article-title":"Peripartum neuroactive steroid and gamma-aminobutyric acid profiles in women at-risk for postpartum depression","volume":"70","author":"Deligiannidis","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0450","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neuroscience.2013.07.002","article-title":"CRH receptor antagonism reverses the effect of social subordination upon central GABAA receptor binding in estradiol-treated ovariectomized female rhesus monkeys","volume":"250","author":"Michopoulos","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/bs.acc.2019.11.004_bb0455","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brainres.2010.08.071","article-title":"Glutamate regulation of GnRH neuron excitability","volume":"1364","author":"Iremonger","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/bs.acc.2019.11.004_bb0460","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1210\/endo-125-2-1090","article-title":"Pulsatile release of gonadotropin-releasing hormone from hypothalamic explants is restrained by blockade of N-methyl-D,L-aspartate receptors","volume":"125","author":"Bourguignon","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0465","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.neuint.2005.12.013","article-title":"Localization and osmotic regulation of vesicular glutamate transporter-2 in magnocellular neurons of the rat hypothalamus","volume":"48","author":"Hrabovszky","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/bs.acc.2019.11.004_bb0470","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3181\/00379727-206-43783","article-title":"The anterior pituitary gland as a possible site of action of kainic acid","volume":"206","author":"Zanisi","year":"1994","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/bs.acc.2019.11.004_bb0475","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2017.0153","article-title":"Opinion on monoaminergic contributions to traits and temperament","volume":"373","author":"Robbins","year":"2018","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0480","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1210\/endo-99-2-411","article-title":"Effects of intraventricular catecholamines on luteinizing hormone release in ovariectomized-steroid-primed rats","volume":"99","author":"Krieg","year":"1976","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ror.0.0020001","article-title":"Noradrenergic regulation of cyclic GnRH secretion","volume":"2","author":"Herbison","year":"1997","journal-title":"Rev. Reprod."},{"key":"10.1016\/bs.acc.2019.11.004_bb0490","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000123301","article-title":"Differential effects of central adrenoceptor agonists on luteinizing hormone release","volume":"34","author":"Leung","year":"1982","journal-title":"Neuroendocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0495","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000107770","article-title":"17-Beta-estradiol directly regulates the expression of adrenergic receptors and kisspeptin\/GPR54 system in GT1-7 GnRH neurons","volume":"86","author":"Jacobi","year":"2007","journal-title":"Neuroendocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0500","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1196\/annals.1429.030","article-title":"Menstrual cycle dysfunction associated with neurologic and psychiatric disorders: their treatment in adolescents","volume":"1135","author":"Joffe","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0505","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1210\/endo-86-5-988","article-title":"Role of catecholamines in stimulating the release of pituitary ovulating hormone(s) in rats","volume":"86","author":"Rubinstein","year":"1970","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0510","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0188-4409(01)00325-3","article-title":"Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome","volume":"32","author":"Barontini","year":"2001","journal-title":"Arch. Med. Res."},{"key":"10.1016\/bs.acc.2019.11.004_bb0515","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1677\/JOE-07-0536","article-title":"Direct effects of prolactin and dopamine on the gonadotroph response to GnRH","volume":"197","author":"Henderson","year":"2008","journal-title":"J. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0520","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/en.2012-1602","article-title":"Dopamine regulation of gonadotropin-releasing hormone neuron excitability in male and female mice","volume":"154","author":"Liu","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0525","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neubiorev.2016.11.021","article-title":"Is there a role for ghrelin in central dopaminergic systems? Focus on nigrostriatal and mesocorticolimbic pathways","volume":"73","author":"Stievenard","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.acc.2019.11.004_bb0530","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/me.2005-0109","article-title":"Serotonin (5-HT) receptor subtypes mediate specific modes of 5-HT-induced signaling and regulation of neurosecretion in gonadotropin-releasing hormone neurons","volume":"20","author":"Wada","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0535","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0022-3565(25)24854-6","article-title":"Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes","volume":"238","author":"De Vivo","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.acc.2019.11.004_bb0540","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/en.2013-1692","article-title":"Serotonin acts through 5-HT1 and 5-HT2 receptors to exert biphasic actions on GnRH neuron excitability in the mouse","volume":"155","author":"Bhattarai","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0545","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0924-977X(97)00031-X","article-title":"Reduced extracellular levels of serotonin in the amygdala of androgenized female rats","volume":"7","author":"Sundblad","year":"1997","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0550","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1210\/endo.139.10.6267","article-title":"Muscarinic regulation of intracellular signaling and neurosecretion in gonadotropin-releasing hormone neurons","volume":"139","author":"Krsmanovic","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0555","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1210\/en.2012-1554","article-title":"Multiple cholinergic signaling pathways in pituitary gonadotrophs","volume":"154","author":"Zemkova","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0560","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/S0196-9781(02)00306-6","article-title":"Endogenous opiates and behavior: 2001","volume":"23","author":"Bodnar","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/bs.acc.2019.11.004_bb0565","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0278-5846(01)00161-0","article-title":"Role of endogenous opioid system in the regulation of the stress response","volume":"25","author":"Drolet","year":"2001","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/bs.acc.2019.11.004_bb0570","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1126\/science.1060952","article-title":"Regional mu opioid receptor regulation of sensory and affective dimensions of pain","volume":"293","author":"Zubieta","year":"2001","journal-title":"Science"},{"key":"10.1016\/bs.acc.2019.11.004_bb0575","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/archpsyc.63.11.1199","article-title":"Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women","volume":"63","author":"Kennedy","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/bs.acc.2019.11.004_bb0580","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0304-3940(91)90489-G","article-title":"Sleep deprivation decreases mu and delta opioid receptor binding in the rat limbic system","volume":"129","author":"Fadda","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/bs.acc.2019.11.004_bb0585","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.1091062","article-title":"Neuroscience. Feeling the pain of social loss","volume":"302","author":"Panksepp","year":"2003","journal-title":"Science"},{"key":"10.1016\/bs.acc.2019.11.004_bb0590","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1126\/science.197601","article-title":"Beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland","volume":"197","author":"Guillemin","year":"1977","journal-title":"Science"},{"key":"10.1016\/bs.acc.2019.11.004_bb0595","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.acc.2019.11.004_bb0600","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/267495a0","article-title":"Endogenous opioid peptides: multiple agonists and receptors","volume":"267","author":"Lord","year":"1977","journal-title":"Nature"},{"key":"10.1016\/bs.acc.2019.11.004_bb0605","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0014-5793(94)00561-3","article-title":"Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type","volume":"347","author":"Bunzow","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/bs.acc.2019.11.004_bb0610","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1471-4159.1995.64010034.x","article-title":"Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family","volume":"64","author":"Lachowicz","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.acc.2019.11.004_bb0615","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/humrep\/den273","article-title":"Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome","volume":"23","author":"Ahmed","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/bs.acc.2019.11.004_bb0620","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2174\/138161206776055895","article-title":"Role of opioid antagonists in the treatment of women with glucoregulation abnormalities","volume":"12","author":"Guido","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/bs.acc.2019.11.004_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.1993.tb01744.x","article-title":"The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women","volume":"39","author":"Pasquali","year":"1993","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/bs.acc.2019.11.004_bb0630","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.npep.2006.07.001","article-title":"Role of neuropeptides in appetite regulation and obesity--a review","volume":"40","author":"Arora","year":"2006","journal-title":"Neuropeptides"},{"key":"10.1016\/bs.acc.2019.11.004_bb0635","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0015-0282(16)60060-2","article-title":"The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism","volume":"50","author":"Barbieri","year":"1988","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.acc.2019.11.004_bb0640","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0035-1564094","article-title":"Beta-endorphins plasma level is higher in lean polycystic ovary syndrome (PCOS) women","volume":"124","author":"Kialka","year":"2016","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/bs.acc.2019.11.004_bb0645","first-page":"191","article-title":"Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease","volume":"82","author":"Fulghesu","year":"1993","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0650","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0015-0282(16)55851-8","article-title":"Long-term naltrexone treatment normalizes the pituitary response to gonadotropin-releasing hormone in polycystic ovarian syndrome","volume":"59","author":"Lanzone","year":"1993","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.acc.2019.11.004_bb0655","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2265.1984.tb00114.x","article-title":"Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome","volume":"20","author":"Cumming","year":"1984","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/bs.acc.2019.11.004_bb0660","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1359-6101(99)00013-1","article-title":"The insulin-like growth factor (IGF) system and gonadotropin regulation: actions and interactions","volume":"10","author":"Lackey","year":"1999","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/bs.acc.2019.11.004_bb0665","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1210\/jcem-59-2-298","article-title":"The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle","volume":"59","author":"Snowden","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0670","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0960-0760(95)00072-8","article-title":"Effects of steroids on the brain opioid system","volume":"53","author":"Piva","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0675","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/endo-118-2-558","article-title":"A decline in endogenous opioid influence during the steroid-induced hypersecretion of luteinizing hormone in the rat","volume":"118","author":"Gabriel","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0680","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1159\/000124495","article-title":"Stimulatory and inhibitory effects of the opioids on gonadotropin secretion","volume":"42","author":"Piva","year":"1986","journal-title":"Neuroendocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0685","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1210\/jcem-55-5-877","article-title":"Effect of sex steroids on beta-endorphin in hypophyseal portal blood","volume":"55","author":"Wardlaw","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0690","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000065953","article-title":"Estrogen modulation of mu-opioid receptor-stimulated [35S]-GTP-gamma-S binding in female rat brain visualized by in vitro autoradiography","volume":"76","author":"Acosta-Martinez","year":"2002","journal-title":"Neuroendocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0695","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/276190a0","article-title":"Morphine and beta-endorphin influence the secretion of the endocrine pancreas","volume":"276","author":"Ipp","year":"1978","journal-title":"Nature"},{"key":"10.1016\/bs.acc.2019.11.004_bb0700","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0015-0282(16)48191-4","article-title":"Elevated plasma levels of beta-endorphin in a group of women with polycystic ovarian disease","volume":"42","author":"Aleem","year":"1984","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.acc.2019.11.004_bb0705","first-page":"630","article-title":"Elevated levels of plasma beta-endorphin and gamma 3-melanocyte stimulating hormone in the polycystic ovary syndrome","volume":"63","author":"Wortsman","year":"1984","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0710","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/0026-0495(87)90135-1","article-title":"Sensitivity to beta-endorphin as a cause of human obesity","volume":"36","author":"Giugliano","year":"1987","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/bs.acc.2019.11.004_bb0715","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jcem-52-3-592","article-title":"beta-Endorphin stimulates the secretion of insulin and glucagon in humans","volume":"52","author":"Reid","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0720","first-page":"89","article-title":"Glucose homeostasis and endogenous opioid peptides","volume":"28","author":"Ramabadran","year":"1990","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0725","first-page":"R59","article-title":"Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans","volume":"261","author":"Bertino","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0730","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.fertnstert.2006.01.039","article-title":"Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women","volume":"86","author":"Hadziomerovic","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.acc.2019.11.004_bb0735","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0740","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1210\/jcem-51-1-179","article-title":"The role of endogenous opiates in LH secretion during the menstrual cycle","volume":"51","author":"Quigley","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0745","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/0002-9378(92)91781-5","article-title":"Increased circulating levels of immunoreactive beta-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion","volume":"167","author":"Carmina","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0750","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/eje.1.02024","article-title":"Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome","volume":"153","author":"Hahn","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0755","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/humrep\/dem108","article-title":"Quality of life and psychological well being in polycystic ovary syndrome","volume":"22","author":"Barnard","year":"2007","journal-title":"Hum. Reprod."},{"key":"10.1016\/bs.acc.2019.11.004_bb0760","first-page":"59","volume":"988","author":"Zhao","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0765","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00213-013-3389-x","article-title":"5-HT(1A) [corrected] receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function","volume":"231","author":"Garcia-Garcia","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.acc.2019.11.004_bb0770","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2008.03725.x","article-title":"Anxiety-related behavior and biogenic amine pathways in the rat following bilateral vestibular lesions","volume":"1164","author":"Darlington","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0775","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/j.2051-5545.2010.tb00298.x","article-title":"Pathophysiology of depression: do we have any solid evidence of interest to clinicians?","volume":"9","author":"Hasler","year":"2010","journal-title":"World Psychiatry"},{"key":"10.1016\/bs.acc.2019.11.004_bb0780","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.mp.4001362","article-title":"GABAergic dysfunction in mood disorders","volume":"8","author":"Brambilla","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/bs.acc.2019.11.004_bb0785","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0790","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00429-008-0189-x","article-title":"Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression","volume":"213","author":"Drevets","year":"2008","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/bs.acc.2019.11.004_bb0795","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroscience.2007.09.005","article-title":"Effects of letrozole on hippocampal and cortical catecholaminergic neurotransmitter levels, neural cell adhesion molecule expression and spatial learning and memory in female rats","volume":"151","author":"Aydin","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/bs.acc.2019.11.004_bb0800","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.npep.2012.08.005","article-title":"Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis","volume":"46","author":"Holzer","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/bs.acc.2019.11.004_bb0805","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1172\/JCI30227","article-title":"Gastrointestinal regulation of food intake","volume":"117","author":"Cummings","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2019.11.004_bb0810","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.beem.2014.03.003","article-title":"The hypothalamic arcuate nucleus and the control of peripheral substrates","volume":"28","author":"Joly-Amado","year":"2014","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0815","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s13311-017-0585-0","article-title":"Anxiety, depression, and the microbiome: a role for gut peptides","volume":"15","author":"Lach","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/bs.acc.2019.11.004_bb0820","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","article-title":"High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome","volume":"65","author":"De Filippis","year":"2016","journal-title":"Gut"},{"key":"10.1016\/bs.acc.2019.11.004_bb0825","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/mp.2017.38","article-title":"Cafeteria diet and probiotic therapy: cross talk among memory, neuroplasticity, serotonin receptors and gut microbiota in the rat","volume":"23","author":"Beilharz","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/bs.acc.2019.11.004_bb0830","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acscentsci.7b00101","article-title":"Hungering for obesity treatments","volume":"3","author":"Madhusoodanan","year":"2017","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0835","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/nmo.12754","article-title":"Enteroendocrine cells: a review of their role in brain-gut communication","volume":"28","author":"Latorre","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/bs.acc.2019.11.004_bb0840","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1210\/en.2005-0973","article-title":"Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status","volume":"147","author":"Drazen","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0845","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1210\/en.2012-1595","article-title":"A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin","volume":"153","author":"Egerod","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb0850","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s12020-014-0275-1","article-title":"Gastrointestinal hormones and polycystic ovary syndrome","volume":"47","author":"Ma","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/bs.acc.2019.11.004_bb0855","doi-asserted-by":"crossref","first-page":"R885","DOI":"10.1152\/ajpregu.00520.2015","article-title":"GLP-1 and weight loss: unraveling the diverse neural circuitry","volume":"310","author":"Kanoski","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0860","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.autneu.2006.10.005","article-title":"Neuropeptide Y receptors; antisecretory control of intestinal epithelial function","volume":"133","author":"Cox","year":"2007","journal-title":"Auton. Neurosci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0865","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0149-7634(01)00066-5","article-title":"The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y","volume":"26","author":"Kask","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.acc.2019.11.004_bb0870","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2174\/156802607782341037","article-title":"Relevance of neuropeptide Y (NPY) in psychiatry","volume":"7","author":"Eaton","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/bs.acc.2019.11.004_bb0875","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jnr.20200","article-title":"Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation","volume":"77","author":"Sorensen","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/bs.acc.2019.11.004_bb0880","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-009-1610-8","article-title":"Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect","volume":"206","author":"Fendt","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.acc.2019.11.004_bb0885","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nrendo.2010.93","article-title":"Bowels control brain: gut hormones and obesity","volume":"6","author":"Field","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0890","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nature00887","article-title":"Gut hormone PYY(3-36) physiologically inhibits food intake","volume":"418","author":"Batterham","year":"2002","journal-title":"Nature"},{"key":"10.1016\/bs.acc.2019.11.004_bb0895","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.regpep.2007.09.011","article-title":"The role of PYY in feeding regulation","volume":"145","author":"Ueno","year":"2008","journal-title":"Regul. Pept."},{"key":"10.1016\/bs.acc.2019.11.004_bb0900","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12031-007-9007-9","article-title":"Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema","volume":"33","author":"Dumont","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0905","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/jpet.103.051821","article-title":"Characterization of blood-brain barrier permeability to PYY3-36 in the mouse","volume":"306","author":"Nonaka","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.acc.2019.11.004_bb0910","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.nut.2008.06.007","article-title":"Y eat?","volume":"24","author":"Chee","year":"2008","journal-title":"Nutrition"},{"key":"10.1016\/bs.acc.2019.11.004_bb0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18020273","article-title":"From belly to brain: targeting the ghrelin receptor in appetite and food intake regulation","volume":"18","author":"Howick","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0920","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/157015909787602779","article-title":"Ghrelin in central neurons","volume":"7","author":"Ferrini","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0925","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0896-6273(03)00063-1","article-title":"The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis","volume":"37","author":"Cowley","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/bs.acc.2019.11.004_bb0930","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"Muller","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb0935","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2174\/1389450118666170227153940","article-title":"Current drug targets in obesity pharmacotherapy\u2013a review","volume":"18","author":"Bhat","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/bs.acc.2019.11.004_bb0940","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nn.2139","article-title":"The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress","volume":"11","author":"Lutter","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0945","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.peptides.2005.04.025","article-title":"Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens","volume":"26","author":"Naleid","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/bs.acc.2019.11.004_bb0950","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049557","article-title":"Concomitant release of ventral tegmental acetylcholine and accumbal dopamine by ghrelin in rats","volume":"7","author":"Jerlhag","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2019.11.004_bb0955","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.npep.2010.02.002","article-title":"Effects of centrally-injected glucagon-like peptide-1 on pilocarpine-induced seizures, anxiety and locomotor and exploratory activity in rat","volume":"44","author":"Gulec","year":"2010","journal-title":"Neuropeptides"},{"key":"10.1016\/bs.acc.2019.11.004_bb0960","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbr.2009.06.020","article-title":"Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways","volume":"204","author":"Iwai","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.acc.2019.11.004_bb0965","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1476-5381.2011.01326.x","article-title":"Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y","volume":"163","author":"Painsipp","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.acc.2019.11.004_bb0970","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1601-183X.2008.00389.x","article-title":"Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice","volume":"7","author":"Painsipp","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/bs.acc.2019.11.004_bb0975","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neubiorev.2014.02.006","article-title":"A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior","volume":"42","author":"McLaughlin","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.acc.2019.11.004_bb0980","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1515\/revneuro-2012-0052","article-title":"Contribution of serotonin type 3 receptors in the successful extinction of cued or contextual fear conditioned responses: interactions with GABAergic signaling","volume":"23","author":"Park","year":"2012","journal-title":"Rev. Neurosci."},{"key":"10.1016\/bs.acc.2019.11.004_bb0985","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuroscience.2012.05.022","article-title":"Cholecystokinin knock-down in the basolateral amygdala has anxiolytic and antidepressant-like effects in mice","volume":"218","author":"Del Boca","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/bs.acc.2019.11.004_bb0990","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.neuroscience.2014.07.062","article-title":"Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice","volume":"277","author":"Desai","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/bs.acc.2019.11.004_bb0995","first-page":"137","article-title":"Brain-gut axis and its role in the control of food intake","volume":"55","author":"Konturek","year":"2004","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/bs.acc.2019.11.004_bb1000","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1159\/000430229","article-title":"Nutritional aspects of depression","volume":"37","author":"Lang","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/bs.acc.2019.11.004_bb1005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000257421","article-title":"Hypothalamic Ghrelin suppresses pulsatile secretion of luteinizing hormone via beta-endorphin in ovariectomized rats","volume":"90","author":"Ogata","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/bs.acc.2019.11.004_bb1010","first-page":"324","article-title":"Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/bs.acc.2019.11.004_bb1015","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jc.2002-021451","article-title":"Circulating ghrelin concentrations in the polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb1020","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1447-0756.2008.00819.x","article-title":"Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome","volume":"34","author":"Bideci","year":"2008","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/bs.acc.2019.11.004_bb1025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-2004-814341","article-title":"Elevated ghrelin plasma levels in patients with polycystic ovary syndrome","volume":"36","author":"Wasko","year":"2004","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/bs.acc.2019.11.004_bb1030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1530\/EJE-07-0683","article-title":"Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome","volume":"158","author":"Barber","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb1035","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/BF03349222","article-title":"Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome","volume":"30","author":"Micic","year":"2007","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/bs.acc.2019.11.004_bb1040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/cen.12619","article-title":"Biomarkers and insulin sensitivity in women with polycystic ovary syndrome: characteristics and predictive capacity","volume":"83","author":"Cassar","year":"2015","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/bs.acc.2019.11.004_bb1045","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1210\/jc.2013-1526","article-title":"Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive","volume":"98","author":"Arusoglu","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2019.11.004_bb1050","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.peptides.2011.03.001","article-title":"Ghrelin and glucose homeostasis","volume":"32","author":"Delhanty","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/bs.acc.2019.11.004_bb1055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/09513590802302233","article-title":"Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters","volume":"24","author":"Mitkov","year":"2008","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb1060","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/er.2002-0029","article-title":"Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin","volume":"25","author":"van der Lely","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/bs.acc.2019.11.004_bb1065","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/humrep\/dei055","article-title":"Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls","volume":"20","author":"Panidis","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/bs.acc.2019.11.004_bb1070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1507\/endocrj.EJ15-0318","article-title":"Low circulating ghrelin levels in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"63","author":"Gao","year":"2016","journal-title":"Endocr. J."},{"key":"10.1016\/bs.acc.2019.11.004_bb1075","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/ajcn\/86.5.1603","article-title":"Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome","volume":"86","author":"Moran","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/bs.acc.2019.11.004_bb1080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/09513590.2011.593670","article-title":"Pro12Ala PPAR gamma2 gene polymorphism in PCOS women: the role of compounds regulating satiety","volume":"28","author":"Bidzinska-Speichert","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/bs.acc.2019.11.004_bb1085","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2265.2008.03285.x","article-title":"Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovarian syndrome (PCOS)","volume":"69","author":"Tsilchorozidou","year":"2008","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"Suppl 2","key":"10.1016\/bs.acc.2019.11.004_bb1090","first-page":"161","article-title":"Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome","volume":"59","author":"Zwirska-Korczala","year":"2008","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/bs.acc.2019.11.004_bb1095","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1093\/humrep\/dev231","article-title":"Gastrointestinal hormone secretion in women with polycystic ovary syndrome: an observational study","volume":"30","author":"Lin","year":"2015","journal-title":"Hum. Reprod."},{"key":"10.1016\/bs.acc.2019.11.004_bb1100","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.coph.2013.09.014","article-title":"Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery","volume":"13","author":"Holst","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/bs.acc.2019.11.004_bb1105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1530\/EC-17-0034","article-title":"Effect of oral contraceptives and\/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome","volume":"6","author":"Glintborg","year":"2017","journal-title":"Endocr. Connect."},{"key":"10.1016\/bs.acc.2019.11.004_bb1110","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1089\/jwh.2010.2272","article-title":"The incretin effect and secretion in obese and lean women with polycystic ovary syndrome: a pilot study","volume":"20","author":"Pontikis","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/bs.acc.2019.11.004_bb1115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/cen.12468","article-title":"Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome","volume":"81","author":"Aydin","year":"2014","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/bs.acc.2019.11.004_bb1120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/17512433.2017.1292125","article-title":"GLP-1 receptor agonists in the treatment of polycystic ovary syndrome","volume":"10","author":"Lamos","year":"2017","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/bs.acc.2019.11.004_bb1125","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","article-title":"GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis","volume":"39","author":"Han","year":"2019","journal-title":"Reprod. Biomed. Online"}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242319301015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242319301015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:39:25Z","timestamp":1758742765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242319301015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128211663"],"references-count":224,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2019.11.004","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}